| Caregiver Outcomes of Alzheimer's Disease Screening (NCT03300180) | Indiana University | 2018-10-15 |
| Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples (NCT03721042) | Nouvelle Clinique Bonnefon | 2018-10-11 |
| Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients (NCT03435861) | University Hospital, Toulouse | 2018-10-08 |
| Repetitive TMS of the Posterior DMN in AD (NCT05454540) | I.R.C.C.S. Fondazione Santa Lucia | 2018-10-01 |
| A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers (NCT03698695) | Theranexus | 2018-09-27 |
| Neuropsychological and Neurophysiological Effects of Cognitive Stimulation in Patients With Alzheimer's Disease and Mild Cognitive Impairment (NCT03784183) | University of Roma La Sapienza | 2018-09-27 |
| Multimodal Biomarkers for Diagnosis and Prognosis in CAA (NCT03969732) | National Taiwan University Hospital | 2018-09-27 |
| A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 (NCT03538522) | Biomed Industries, Inc. | 2018-09-15 |
| OCT Angiography and NRAI in Dementia (NCT03761381) | Oregon Health and Science University | 2018-09-14 |
| Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (NCT03533257) | Amylyx Pharmaceuticals Inc. | 2018-09-14 |
| A Dyadic Sleep Intervention for Alzheimer's Disease Patients and Their Caregivers (NCT03455569) | University of California, Los Angeles | 2018-09-11 |
| Caregiver Study Dr. Phillips (NCT03653871) | AdventHealth | 2018-09-11 |
| Imaging Inflammation in Alzheimer's Disease With 11C-ER176 (NCT03744312) | Columbia University | 2018-09-10 |
| Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults (NCT03711825) | Lyndra Inc. | 2018-09-10 |
| Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease (NCT04606420) | Preventive Medicine Research Institute | 2018-09-08 |
| REGEnLIFE RGn530 - Feasibility Pilot (NCT03672474) | University Hospital, Montpellier | 2018-09-07 |
| Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease (NCT03676881) | Bruyère Health Research Institute. | 2018-09-04 |
| Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects (NCT03466736) | University of Utah | 2018-09-01 |
| The China Longitudinal Aging Study of Cognitive Impairment (NCT03672448) | Shanghai Mental Health Center | 2018-09-01 |
| Network Modulation in Alzheimer's Disease (NCT04045990) | Brigham and Women's Hospital | 2018-09-01 |
| Identifying Biomarkers in Alzheimer's Disease (NCT05655650) | Chinese University of Hong Kong | 2018-09-01 |
| Systematic Multi-domain Alzheimer's Risk Reduction Trial (NCT03683394) | Kaiser Permanente | 2018-08-30 |
| Age-related Hearing Loss and Lexical Disorders (NCT03638323) | Groupe Hospitalier de la Rochelle Ré Aunis | 2018-08-27 |
| Florbetaben PET Imaging in PPA (NCT04720001) | University of Chicago | 2018-08-23 |
| Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) (NCT03443973) | Hoffmann-La Roche | 2018-08-22 |
| Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease (NCT03405662) | University of California, San Francisco | 2018-08-16 |
| The A-LIST WMM Insights Series (NCT04466722) | UsAgainstAlzheimer's | 2018-08-15 |
| Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Early Alzheimer's Disease (NCT03612622) | Anhui Medical University | 2018-08-14 |
| Detecting Probable Alzheimer's Disease From Speech Using Linguistical Analysis (NCT04041895) | East Tennessee State University | 2018-08-13 |
| Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production (NCT03551769) | Cerecin | 2018-08-05 |
| Dementia-specific Intervention of Advance Care Planning (NCT03615027) | University of Lausanne Hospitals | 2018-08-03 |
| Effect of Modulating Gamma Oscillations Using tACS (NCT03412604) | Massachusetts General Hospital | 2018-08-02 |
| Studies of Brain and Body Interaction (NCT03672266) | Rutgers University | 2018-08-01 |
| Auricular Point Acupressure to Manage Pain in Patients With Alzheimer's Disease and Related Disorders (NCT03393546) | Johns Hopkins University | 2018-08-01 |
| A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density (NCT03577262) | Alkermes, Inc. | 2018-07-23 |
| Evidence Amyloid Scan EEG Study (NCT03644043) | Metabolic Therapy Inc. | 2018-07-20 |
| The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease (NCT04021888) | Dokuz Eylul University | 2018-07-16 |
| Brain Energy for Amyloid Transformation in Alzheimer's Disease Study (NCT03472664) | Wake Forest University Health Sciences | 2018-07-16 |
| BarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors Disclosure (NCT03847038) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2018-07-16 |
| ANAVEX2-73 for Treatment of Early Alzheimer's Disease (NCT03790709) | Anavex Life Sciences Corp. | 2018-07-03 |
| Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) (NCT03444870) | Hoffmann-La Roche | 2018-06-06 |
| Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain (NCT03510572) | Asan Medical Center | 2018-06-04 |
| Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) (NCT03661034) | Cognito Therapeutics, Inc. | 2018-05-31 |
| Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease (NCT03522129) | Cognition Therapeutics | 2018-05-30 |
| Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat) (NCT03587376) | Janssen Research & Development, LLC | 2018-05-30 |
| Music Therapy for Persons With Dementia (NCT03643003) | University of Iowa | 2018-05-25 |
| Nonverbal Communication in Aged People (NCT04146688) | University Hospital, Lille | 2018-05-17 |
| Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss (NCT03587649) | Invicro | 2018-05-07 |
| Biomarker Exploration in Aging, Cognition and Neurodegeneration (NCT03860857) | University of California, Irvine | 2018-05-01 |
| Sleep Aging and Risk for Alzheimer's 2.0 (NCT03278119) | NYU Langone Health | 2018-05-01 |
| Longitudinal Early-onset Alzheimer's Disease Study Protocol (NCT03507257) | Indiana University | 2018-04-30 |
| Exploration of the Enteric Nervous System in Alzheimer Disease (NCT03472183) | Nantes University Hospital | 2018-04-26 |
| Multi-Center Study of Sensory Stimulation to Improve Brain Function (NCT03556280) | Cognito Therapeutics, Inc. | 2018-04-24 |
| UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy (NCT03503331) | University of Alabama at Birmingham | 2018-04-20 |
| Prevention of Cognitive Decline in Older Adults With Low Dha/Epa Index in Red Blood Cells (NCT03691519) | University Hospital, Toulouse | 2018-04-17 |
| Hormone Replacement Trial Against ALzheimers' Disease (NCT04312399) | University Hospital, Ghent | 2018-04-17 |
| The Effect of Music in Alzheimer's Patients (NCT05125536) | Eskisehir Osmangazi University | 2018-04-16 |
| A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease (NCT03520998) | Alkahest, Inc. | 2018-04-16 |
| Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease (NCT04057807) | Yale University | 2018-04-15 |
| Sustainable Method for Alzheimer's Prediction (NCT03654911) | Catholic University of the Sacred Heart | 2018-04-11 |
| ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer Patients (NCT03444181) | University of Bergen | 2018-04-11 |
| SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate (NCT03944460) | Prof. Dr. Dieter Willbold | 2018-04-09 |
| tES Effects on Associative Memory Performance (NCT03351452) | University of Bern | 2018-04-09 |
| Lexical Priming by Music in Alzheimer's Disease and Healthy Aging (NCT03342326) | Centre Hospitalier Universitaire de Saint Etienne | 2018-04-03 |
| Effect of CT1812 Treatment on Brain Synaptic Density (NCT03493282) | Cognition Therapeutics | 2018-03-28 |
| Orexin and Tau Pathology in Cognitively Normal Elderly (NCT03053908) | NYU Langone Health | 2018-03-27 |
| PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease (NCT04052737) | Pharmazz, Inc. | 2018-03-23 |
| Efficacy and Safety of MMFS in Early AD (NCT03531684) | Neurocentria, Inc. | 2018-03-20 |
| Bilateral Brain Dynamics in Cognition and Aging (NCT03224988) | Duke University | 2018-03-20 |
| Optimizing Care for Patients With Dementia (NCT03442322) | University of Pittsburgh | 2018-03-15 |
| Blood Biomarker of Alzheimer's Disease (AD) (NCT03340571) | Duke University | 2018-03-12 |
| Phase 1 Test-retest Evaluation of [18F]MNI-958 PET (NCT03545789) | Invicro | 2018-03-12 |
| Tau Screening Study in Subjects With Early Symptomatic AD (NCT03467477) | Avid Radiopharmaceuticals | 2018-03-08 |
| A Multiple Ascending Dose Study of COR388 (NCT03418688) | Cortexyme Inc. | 2018-03-06 |
| Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease (NCT03466177) | Universitaire Ziekenhuizen KU Leuven | 2018-03-01 |
| Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers (NCT03902548) | Five Eleven Pharma, Inc. | 2018-02-21 |
| Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) (NCT07496918) | Massachusetts Institute of Technology | 2018-02-20 |
| Anti-viral Therapy in Alzheimer's Disease (NCT03282916) | Columbia University | 2018-02-12 |
| Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease. (NCT03851523) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2018-02-12 |
| Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients (NCT03630419) | Perseverance Research Center, LLC | 2018-02-10 |
| NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers (NCT03289377) | University of Washington | 2018-02-01 |
| Repetitive TMS of the Default Mode Network in AD (NCT03778151) | I.R.C.C.S. Fondazione Santa Lucia | 2018-02-01 |
| Gut Microbiota and Alzheimer's Diseases (NCT03827733) | Shanghai 10th People's Hospital | 2018-02-01 |
| CBT for African Americans With Cognitive Impairment (NCT03384069) | Emory University | 2018-01-10 |
| Coaching for Cognition in Alzheimer's (COCOA) (NCT03424200) | Hoag Memorial Hospital Presbyterian | 2018-01-10 |
| Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease (NCT03384043) | Baylor University | 2018-01-08 |
| Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy (NCT03657745) | Alzheimer's Light LLC | 2018-01-01 |
| Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease (NCT03352024) | University Hospital, Montpellier | 2018-01-01 |
| Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease (NCT03402659) | EIP Pharma Inc | 2017-12-29 |
| A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease (NCT03375697) | Janssen Research & Development, LLC | 2017-12-22 |
| Ectosomes, New Biomarkers of Tau Pathology? (NCT03381482) | University Hospital, Lille | 2017-12-20 |
| A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) (NCT03367403) | Eli Lilly and Company | 2017-12-18 |
| Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD (NCT03461276) | Araclon Biotech S.L. | 2017-12-13 |
| EPIC: An Intervention for Early-stage AD Dyads - Adapted for Virtual Delivery (NCT03144921) | Arizona State University | 2017-12-12 |
| Vielight Neuro RX Gamma - Feasibility Pilot (NCT03328195) | Vielight Inc. | 2017-12-04 |
| Retinal Metabolic Imaging of Alzheimer Patient (NCT03420807) | Optina Diagnostics Inc. | 2017-12-04 |
| Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment (NCT03446001) | TauRx Therapeutics Ltd | 2017-12-01 |
| Decisions About Cancer Screening in Alzheimer's Disease (NCT03282097) | Indiana University | 2017-12-01 |
| Fornix and NbM as Targets of Stimulation In Alzheimer's Disease (NCT03352739) | Xuanwu Hospital, Beijing | 2017-12-01 |
| The Use of Transcranial Focused Ultrasound for the Treatment of Neurodegenerative Dementias (NCT04250376) | Neurological Associates of West Los Angeles | 2017-11-27 |